3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Neoplasms
2
Colorectal Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Lung Neoplasms
1
Inflammation
1
Colonic Neoplasms
1
Cachexia
1
Biliary Tract Neoplasms
1
Anus Neoplasms
1
Interventions
Blood Specimen Collection
3
Standard of Care
2
Diet Therapy
2
telotristat ethyl
1
remune
1
ostarine
1
nabiximols
1
irinotecan sucrosofate
1
dermcidin
1
bermekimab
1
anamorelin
1
Resistance Training
1
Powders
1
Omacor
1
Olanzapine
1
Nutritional Status
1
Melatonin
1
Megestrol Acetate
1
Infliximab
1
Immunologic Techniques
1
Ibuprofen
1
Gemcitabine
1
Fluorouracil
1
Exercise
1
Enteral Nutrition
1
Cyproheptadine
1
Curcumin
1
Calorimetry, Indirect
1
Calorimetry
1
Body Height
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cachexia
×
Ibuprofen
×
Gastrointestinal
×
Clear all
NCT04907864
2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2
Unknown
112 enrolled